Newsfeeds Archive - Page 2 of 8

3 minute read

US Stocks Higher; Schlumberger Earnings Beat Estimates

January 19, 10:53 AM

U.S. stocks traded higher this morning, with the Dow Jones index gaining more than 50 points on Friday. Following the market opening Friday, the Dow traded up 0.18% to 37,536.76 while the NASDAQ rose 0.38% to 15,113.04. The S&P 500 also rose, gaining, 0.19% to 4,790.00.

AXDX

3 minute read

Accelerate Diagnostics Announces Pricing Of ~$15M Public Offering And Private Placement; The Public Offering Price For Each Unit Is $1.50 And The Public Offering Price For Each Pre-Funded Unit Is $1.49

By Benzinga Newsdesk

January 19, 10:21 AM

Accelerate Diagnostics, Inc. (NASDAQ:AXDX) (the "Company") today announced the pricing of an underwritten public offering consisting of 6,860,659 units, each consisting of one share of common stock and one warrant to

AXDX

1 minute read

Movers

12 Health Care Stocks Moving In Friday’s Pre-Market Session

By Benzinga Insights

January 19, 9:06 AM

Gainers Mesoblast (NASDAQ:MESO) shares increased by 22.1% to $2.1 during Friday’s pre-market session. The company’s market cap stands…

ADIL

1 minute read

Movers

12 Health Care Stocks Moving In Tuesday’s Intraday Session

By Benzinga Insights

January 16, 1:31 PM

Gainers Vaxart (NASDAQ:VXRT) shares rose 37.5% to $0.77 during Tuesday’s regular session. The company’s market cap stands at…

ACRS

1 minute read

News

Why Accelerate Diagnostics (AXDX) Stock Hit A New 52-Week Low Today

By Henry Khederian

January 16, 11:37 AM

Accelerate Diagnostics shares are trading lower by 23.2% Tuesday morning. The company announced the initiation of a proposed underwritten public offering.

AXDX

1 minute read

Movers

12 Health Care Stocks Moving In Tuesday’s Pre-Market Session

By Benzinga Insights

January 16, 9:05 AM

Gainers MorphoSys (NASDAQ:MOR) shares moved upwards by 15.1% to $9.9 during Tuesday’s pre-market session. The company’s market cap…

AHG

3 minute read

Accelerate Diagnostics Announces Certain Preliminary Q4 And FY23 Results; FY23 Preliminary Revenue Was ~$12.1M Vs $12.8M YoY; Ended The Year With ~$13.4M In Cash And Cash Equivalents

By Benzinga Newsdesk

January 7, 9:18 PM

Accelerate Diagnostics, Inc. (NASDAQ:AXDX) (Accelerate), an in vitro diagnostics company dedicated to providing services that improve patient outcomes and lower healthcare costs through the rapid diagnosis of serious

AXDX

1 minute read

Earnings

Recap: Accelerate Diagnostics Q3 Earnings

By Benzinga Insights

November 9, 5:55 PM

Accelerate Diagnostics (NASDAQ:AXDX) reported its Q3 earnings results on Thursday, November 9, 2023 at 04:05 PM. Here’s what…

AXDX

22 minute read

Earnings

Earnings Scheduled For November 9, 2023

By Benzinga Insights

November 9, 7:52 AM

Companies Reporting Before The Bell • Indivior (NASDAQ:INDV) is expected to report quarterly earnings at $0.30 per share on revenue of $265.00 million.

AAOI

16 minute read

Earnings

Earnings Scheduled For August 10, 2023

By Benzinga Insights

August 10, 6:59 AM

Companies Reporting Before The Bell • IDEX Biometrics (NASDAQ:IDBA) is estimated to report quarterly loss at $0.39 per share on revenue of $1.60 million.

AACG